USRTX
Price
$33.41
Change
+$0.24 (+0.72%)
Updated
Sep 4 closing price
Net Assets
689.44M
VFFSX
Price
$317.85
Change
-$0.97 (-0.30%)
Updated
Sep 5 closing price
Net Assets
1.37T
Interact to see
Advertisement

USRTX vs VFFSX

Header iconUSRTX vs VFFSX Comparison
Open Charts USRTX vs VFFSXBanner chart's image
Horizon Multi-Factor U.S. Equity Advisor
Price$33.41
Change+$0.24 (+0.72%)
VolumeN/A
Net Assets689.44M
Vanguard 500 Index Institutional Select
Price$317.85
Change-$0.97 (-0.30%)
VolumeN/A
Net Assets1.37T
USRTX vs VFFSX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.37T vs. USRTX (689M). VFFSX pays higher dividends than USRTX: VFFSX (1.18) vs USRTX (0.15). USRTX was incepted earlier than VFFSX: USRTX (6 years) vs VFFSX (9 years). USRTX (1.19) is less costly to investors than VFFSX (0.01). USRTX is a more actively managed with annual turnover of: 164.00 vs. VFFSX (2.00). USRTX has a lower initial minimum investment than VFFSX: USRTX (2500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 17.87 vs. USRTX (4.54). VFFSX return over 5 years is better than : 89.31 vs. USRTX (30.80).
USRTXVFFSXUSRTX / VFFSX
Total Expense Ratio1.190.0111,900%
Annual Report Gross Expense Ratio1.190.0111,900%
Fund Existence6 years9 years-
Gain YTD10.27110.48598%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets689M1.37T0%
Annual Yield % from dividends0.151.1812%
Returns for 1 year4.5417.8725%
Returns for 3 years38.5165.9958%
Returns for 5 years30.8089.3134%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSTX2.200.11
+5.26%
OS Therapies Inc
EXAS53.812.40
+4.67%
Exact Sciences Corp
CMPO18.50-0.06
-0.32%
CompoSecure
TCI46.91-0.24
-0.51%
Transcontinental Realty Investors
SCNI1.50-0.06
-3.85%
Scinai Immunotherapeutics Ltd.